Insilico Medicine Hong Kong Limited

This study tests an oral medication called INS018_055 in 40 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and breathing difficulty. The main goal is to check the drug's safety over 12 weeks. Participants will be randomly assigned to receive …

This study tests a new experimental drug called ISM3412 in about 80 adults with advanced solid tumors that have a specific genetic change (MTAP deletion) and have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. The …

This early-stage study tests a new drug called ISM6331 in people with advanced mesothelioma or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 100 adults w…

This study tests a new drug called ISM5411 in 80 adults with active ulcerative colitis, a chronic bowel disease causing inflammation and discomfort. Participants will receive either the drug or a placebo to see if it safely reduces symptoms. The goal is to control the disease, no…